ArticleHead and neck pathology2025
Cell Proliferation, DNA Damage, and Apoptosis in Oral Leukoplakia and Oral Squamous Cell Carcinoma in Young Patients: A Comparative Immunohistochemical Study.
Article in Head and neck pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the role of oxidative DNA damage, cell proliferation, and apoptosis in oral leukoplakia (OL) and oral squamous cell carcinoma (OSCC) in patients aged 40 years or younger.
methodsSixty-four OL, twenty-eight OSCC and ten normal oral mucosa (NOM) were subjected to immunohistochemistry evaluation of 8-OhDG, Ki-67, Bax, and Bcl-2 using formalin-fixed, paraffin-embedded tissue sections. For the analysis of immunostaining, the immunoreactive score was used for the 8-OhDG, Bax, and Bcl-2 biomarkers, while the labeling index was calculated for Ki-67 quantification. The Mann-Whitney test and Kruskal-Wallis test were used to compare proteins immunoexpression among groups, as well as to assess the association of these markers with clinicopathological features in OL and OSCC cases.
resultsA significantly higher Ki-67 label index was observed in OSCC compared to OL (p = 0.001). Suprabasal Ki-67 expression differed significantly between OL and NOM groups (p = 0.047). No differences were found in immunoexpression of 8-OHDdG, Bax and BCL-2 between groups. Among OL cases, a significantly higher 8-OHdG expression was observed in severe dysplasia compared to mild and non-dysplasia (p = 0.039). Larger OL lesions exhibited lower Bax expression compared to lesions measuring less than 2 cm (p = 0.035). In OSCC, Bcl-2 expression was significantly higher in plaques than in nodular lesions, regardless of ulceration (p = 0.034).
conclusionsThe findings of this study reinforce the relevance of Ki-67 as a proliferation marker in the progression of OL among younger individuals. Additionally, oxidative stress may be involved in OED progression in this population. The expression of pro-apoptotic markers in OL cases indicates more active apoptosis in the early stages, while the expression of anti-apoptotic markers in OSCC cases suggests that different clinical patterns may reflect distinct biological behaviors and stages of tumor progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.